Turnover
≈ €160,000 estimated
The micro format states no turnover.
Dr. Roxanne Devadder
Overview
Lifetime
1 annual account with figurespeak €69,075 (2025)
€69,075
peak €47,239 (2025)
€47,239
peak €52,239 (2025)
€52,239
€11,378
Board1 name since 2025
1 directorDEVADDER Roxanne Marie Kristel
Documentsfilings and deeds
02-07-202629 days before the deadline
2025micro format
Incorporation 21-011 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€5,000 100 shares
Checked score
98
Excellent
Financially stronger than 82% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
02-2026: 0.3%
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.4%▲ +0.1 percentage points vs 06-2026highest value
08-2026: < 0.1%▼ -0.4 percentage points vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 5.51, cash €42,322
Equity €52,239 (82.1% of total assets)
Figures for financial year 2025 (filed on 02-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 84% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as Dr. Roxanne Devadder has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of Dr. Roxanne Devadder itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for Dr. Roxanne Devadder. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.51, above the usual 1.5. Short-term debt is 15.8% and cash 66.5% of total assets. 17.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
29 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1018883644
Incorporation
Founding capital of €5,000, 100 shares · Founder: DEVADDER Roxanne Marie Kristel · Appointment: DEVADDER Roxanne Marie Kristel (director) · published on 21-01-2025 · Gazette deed
First establishment
Eugène Demolderlaan 95, Schaerbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Roxanne Devadder Schaerbeek | €63,617 | €69,075 | 82.1% | - |
| HB Expertise Brussels | €68,997 | €65,445 | 78.4% | - |
| Dr. Margaux Vanderstraeten Merchtem | €66,573 | €70,566 | 85.0% | - |
| DOKTER BINA PAUWELS Bornem | €69,250 | €72,149 | 79.9% | - |
| DOCTEUR MUSIN MARGAUX Beloeil | €65,763 | €65,923 | 65.4% | - |
| Dokter Vandewynckel Bruges | €71,153 | €67,606 | 79.4% | - |
| DS MED Genappe | €65,847 | €64,299 | 96.9% | - |
These companies have the same main activity as Dr. Roxanne Devadder: general medical practice (NACE 86210). They are comparable in size and age: total assets between €65,800 and €71,200, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 17-01-2025Normal situation
- Activity
- General medical practiceNACE 86210and 1 other
- Establishment unit
- 2.369.237.7671030 Schaerbeek, since 17-01-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 01-09-2025
Annual accounts 2025
- €69,075
- €47,239
- €52,239
- €63,617
- Filing
- Filed on 02-07-2026, 29 days before the end of the filing period
Insights on Dr. Roxanne Devadder
Dr. Roxanne Devadder has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €52,239 and a net result of €47,239.
Its solvency ranks better than 73% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 02-07-2026, 29 days before the deadline€69,075
€66,087
€47,239
€45,355
82.1%
5.51
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €160,000. Estimated: probably between €120,000 and €200,000.
Balance sheet
balance sheet total €63,617 on 31-12-2025What the company ownsHow it is paid for
Position in the sector
82.1%
Higher than 73% of 20,767 companies in 2025.
5.51
Higher than 71% of 20,341 companies in 2025.
74.3%
Higher than 94% of 20,623 companies in 2025.
Dr. Roxanne Devadder
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: middle half · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
63,617 | |
21/28 |
8,196 | |
22/27 |
8,196 | |
26 |
8,196 | |
29/58 |
55,422 | |
40/41 |
13,100 | |
40 |
13,100 | |
54/58 |
42,322 | |
| Balance sheet: equity and liabilities | ||
10/49 |
63,617 | |
10/15 |
52,239 | |
10/11 |
5,000 | |
13 |
47,239 | |
133 |
47,239 | |
17/49 |
11,378 | |
42/48 |
10,066 | |
44 |
238 | |
440/4 |
238 | |
45 |
9,385 | |
450/3 |
9,385 | |
47/48 |
443 | |
492/3 |
1,312 | |
| Income statement | ||
9900 |
69,075 | |
630 |
2,988 | |
9901 |
66,087 | |
65/66B |
108 | |
65 |
108 | |
9903 |
65,980 | |
67/77 |
18,740 | |
9904 |
47,239 | |
9905 |
47,239 | |
| Appropriation of the result | ||
9906 |
47,239 | |
691/2 |
47,239 | |
6921 |
47,239 | |
| Document | ||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 02-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 02-07-2026 | 2026-00271655 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 |
|---|---|---|
| 69,075 | ||
| 50,227 | ||
| 8,883 | ||
| 45,355 | ||
| 82.1% | ||
| 5.51 | ||
| 0.22 | ||
| 90.4% | ||
| 74.3% | ||
| over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 |
|---|---|
| Tangible fixed assets | €8,883 |
| €2,988 |
Source: notes to the 2025 annual accounts (statement of fixed assets)
Insights on Dr. Roxanne Devadder
Debt's share of the balance-sheet total is 17.9%.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
since 17-01-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 02-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Het bestuursorgaan zal overeenkomstig artikel 5:73 WVV alle handelingen verrichten die nodig of dienstig zijn tot verwezenlijking van het…”deed of 21-01-2025
Mandates through the years
1 name, the dashed line is todayDEVADDER Roxanne Marie Kristel
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- DEVADDER Roxanne Marie Kristel
- Director (not named in the articles), from 17-01-2025 to date
Control
Founder
This company
Dr. Roxanne Devadder
Equity €52,239
Profit €47,239 in 2025
Capital
- Contribution
- €5,000
- Shares
- 100
- Contribution per share
- €50
- Equity per share
- €522 in 2025
- Source
- deed of 21-01-2025
Articles of association
deed of 21-01-2025 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“Tenzij de algemene vergadering bij hun benoeming anders beslist, worden de bestuurders bezoldigd voor de uitoefening van hun mandaat, De…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 18:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 21-01-2025 ↗
- DEVADDER Roxanne Marie Kristel 100 shares (100%) · €5,000 in cash
Network & group
No group
Dr. Roxanne Devadder has no parent and no holdings in its annual accounts. DEVADDER Roxanne Marie Kristel is the only director. Dr. Roxanne Devadder shares no director with another company.
Timeline
Timeline
4 events since 2025Filings
Establishments
20252026
2026
Annual accounts 2025 filed NBBmicro format · 29 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:1018883644
IncorporationFounding capital of €5,000, 100 shares · Founder: DEVADDER Roxanne Marie Kristel · Appointment: DEVADDER Roxanne Marie Kristel (director) · published on 21-01-20254 points ▸
- Founder, DEVADDER Roxanne Marie Kristel
- Board rule, 1
- Director appointment, DEVADDER Roxanne Marie Kristel (director (not named in the articles))
- Founding capital, €5,000, 100 shares
- The deed holds 2 more points.
First establishment Eugène Demolderlaan 95, Schaerbeek
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
Company details
Identity
- Enterprise number
- 1018.883.644
- VAT number
- BE 1018.883.644
- Peppol ID
- 0208:1018883644
- Other Peppol ID
- 9925:BE1018883644
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 17-01-2025
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 18:00deed of 21-01-2025 (in Dutch)
- Peppol
- Reachable since 01-09-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- Dr. Roxanne Devadder in Dutch
- Entity type
- Legal entity
Activities
NACEBEL 202586210
General medical practice main activity
96999
Other personal services
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Het ter beschikking stellen van alle nodige middelen aan de artsen-aandeelhouders; Het inrichten van alle algemene diensten, zoals een…”deed of 21-01-2025 (in Dutch)
9 activities
- Het ter beschikking stellen van alle nodige middelen aan de artsen-aandeelhouders
- Het inrichten van alle algemene diensten, zoals een medische bibliotheek, en in het bijzonder van een medisch secretariaat, die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten
- Het aankopen, huren en/of leasen van alle medische apparatuur en begeleidende accommodaties voor voornoemde activiteiten
- Het occasioneel verstrekken van onderwijs en het geven van lezingen over voormelde medische onderwerpen, het schrijven en laten publiceren van medische artikels en boeken, het optreden als stagebegeleider
- Het opstellen van expertiseverslagen met betrekking tot de specialisatie van de betrokken arts-aandeelhouder
- Het occasioneel invullen van vragenlijsten, informatieve documenten en enquêtes van bedrijven in de medische sector, dit alles met respect voor het beroepsgeheim en de regels van de deontologie in het algemeen
- Het beheer en de uitbreiding voor eigen rekening van een patrimonium bestaande uit roerende en onroerende goederen zowel in het binnenland als in het buitenland alsmede alle handelingen die daar rechtstreeks of onrechtstreeks verband mee houden of die van aard zijn de opbrengst van haar goederen te bevorderen, zoals de aankoop en de verkoop, huur en verhuur, de ruiling of in het algemeen de verwerving of de overdracht van goederen zo roerende als onroerende, het onderhoud, de ontwikkeling, de verfraaiing en de verhuring van goederen
- Het aanleggen, het oordeelkundig uitbouwen en beheren van een roerend patrimonium, alle verrichtingen met betrekking tot roerende goederen en rechten, van welke aard ook, zoals het verwerven door inschrijving of aankoop en het beheren van aandelen, obligaties, kasbons of andere roerende waarden, van welke vorm ook, van Belgische of buitenlandse, bestaande of nog op te richten rechtspersonen en ondernemingen
- Uitoefening van de geneeskunde door de artsen-aandeelhouders, met specialisatie huisarts, in naam en voor rekening van de vennootschap
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Eugène Demolderlaan 95 registered office 1030 Schaerbeek | 17-01-2025 | 2.369.237.767 |
Buildings and parcels at the address
- Ground area
- 131 m²
- Buildings
- 57 m²
- Volume, LiDAR
- 863 m³
- Tallest building
- 18.7 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21902A0424/00K002 | 131 m² | 1 · 57 m² | 18.7 m · 5 |